A few short months after Charles River Laboratories acquired Cognate BioServices, the company is folding yet another CDMO into its cell and gene network, signing more than $ 1 billion in M&A outlays so far this year. Charles River Laboratories has inked a deal to pay $ 292.5 million in cash for gene therapy CDMO Vigene Biosciences,… Read More »
It’s the mother of all holidays. And after more than a year of social distancing, what better way to spend this Mother’s Day than by enjoying the city’s top to-dos together? As New York continues easing its COVID-19 restrictions — increasing indoor and outdoor capacity at restaurants and entertainment venues — this Sunday’s celebration of… Read More »
A cost-effectiveness analysis has found that injectable, long-lasting antiretroviral therapy (ART) would need to cost no more than $ 131 a year in order to be cost-effective if used for patients who are not fully virally suppressed in lower-income settings in regions like sub-Saharan Africa. The analysis found that injectable cabotegravir/rilpivirine would only reach the… Read More »
The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Who Can Get Vaccinated? Vaccine Questions Advertisement Continue reading the main story Supported by Continue reading the main story Parents, Stop Talking About the ‘Lost Year’ Teenagers and tweens will be fine, experts say — if adults model resilience. Eyan Gallegos, 11, a seventh… Read More »